Results 231 to 240 of about 21,276,636 (264)

FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer. [PDF]

J Biol Chem
Lin J, Qiao X, Liu H, Chen Y, Li Z, Tong X, Shen M, Zhang R, Han Y, Shen J, Wang Z.   +10 more
europepmc   +1 more source

Surgical and pathologic efficacy of neoadjuvant immunochemotherapy in EGFR-mutant non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Liu S, Deng Q, Quan S, Liang W, He J.
europepmc   +1 more source

Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. [PDF]

EClinicalMedicine
Hulskotte LMG, Veerman GDM, Lanser DAC, Reyners AKL, van Schaik RHN, Dingemans AC, Taxis K, Mathijssen RHJ, Jansman FGA.   +8 more
europepmc   +1 more source

A Dual-Responsive Claringbullite-Like Nanozyme for Inhibition of Non-Small Cell Lung Cancer Progression. [PDF]

Small Methods
Chen X, Yang T, Zheng W, Luo Y, Liang R, An S, Liu X.   +6 more
europepmc   +1 more source

Current advances in extended resections for non-small cell lung cancer-a narrative review. [PDF]

Transl Lung Cancer Res
Sinn K, Begic M, Hoda MA, Aigner C.
europepmc   +1 more source

Advanced ALK-EML4 fusion-positive non-small cell lung cancer with intraspinal metastases: a case report. [PDF]

Front Oncol
Lang J, Guo B, Han Q, Xiong Z.
europepmc   +1 more source

Correction to "YY1-Upregulated MTHFD2 Drives Non-Small Cell Lung Cancer Progression Through the Regulation of Lrrk2". [PDF]

J Biochem Mol Toxicol
europepmc   +1 more source

Metagenes Associated with Survival in Non-Small Cell Lung Cancer

Cancer Informatics, 2011
Egon Urgard, Tõnu Vooder, Urmo Võsa, Kristjan Välk, Mingming Liu, Cheng Luo, Fabian Hoti, Retlav Roosipuu, Tarmo Annilo, Jukka Laine, Christopher M. Frenz, Liqing Zhang, Andres Metspalu   +12 more
doaj  

Advancing Clinical Research

Advanced Science, EarlyView.
wiley   +1 more source